©The Author(s) 2026.
World J Gastrointest Pharmacol Ther. Mar 5, 2026; 17(1): 112872
Published online Mar 5, 2026. doi: 10.4292/wjgpt.v17.i1.112872
Published online Mar 5, 2026. doi: 10.4292/wjgpt.v17.i1.112872
Table 3 Predictors of post-endoscopic retrograde cholangiopancreatography pancreatitis in all patients
| Variable | Odds ratio | 95% confidence interval | P value |
| Age < 50 years | 0.43 | 0.07-1.54 | 0.263 |
| Female sex | 0.89 | 0.43-1.86 | 0.757 |
| Intact papilla | 1.81 | 0.86-3.84 | 0.120 |
| Precut sphincterotomy | 2.73 | 0.57-9.87 | 0.155 |
| Biliary sphincterotomy | 1.30 | 0.41-4.19 | 0.661 |
| Sphincteroplasty1 | 4.20 | 1.38-11.44 | 0.007 |
| Rectal indomethacin | 1.34 | 0.55-3.07 | 0.500 |
| Pancreatic duct stent | 1.40 | 0.38-4.05 | 0.566 |
| FCSEMS placement1 | 5.49 | 2.10-16.99 | 0.001 |
| UCSEMS placement | 3.19 | 0.63-13.00 | 0.12 |
| Plastic stent placement | 1.45 | 0.45-3.99 | 0.49 |
- Citation: Zhang LY, Tikhe D, Shrigiriwar A, Ermerak G, Lee HH, Sin L, Turner I, Edwards P, Abi-Hanna D, Hourigan L, Kostalas S, Bassan M. Fully covered metal biliary stents confer a higher risk of post-endoscopic retrograde cholangiopancreatography pancreatitis. World J Gastrointest Pharmacol Ther 2026; 17(1): 112872
- URL: https://www.wjgnet.com/2150-5349/full/v17/i1/112872.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v17.i1.112872